EMD 3.57% 5.8¢ emyria limited

Ann: Broker Briefing Presentation, page-6

  1. 2,071 Posts.
    lightbulb Created with Sketch. 564
    it really is understated that Jazz pharma is following us closely.

    and we are one of the only companies that have done a head-to-head with the leading FDA-approved product which is currently making $1B p.a.
 
watchlist Created with Sketch. Add EMD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.